logo

For the Inventor, By the Inventor

Toronto, Canada

Nono Inc.


USPTO Granted Patents = 38

% Expired Patents = 31.6



Trademarks = 1

Forward Citations = 212

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Michael Tymianski (30 out of 33 patents)

silverMedal Jonathan David Garman (24 out of 28 patents)

bronzeMedal Michael P Belmares (8 out of 19 patents)

4.  Peter S Lu (8 out of 25 patents)

5.  Michael W Salter (5 out of 11 patents)

6.  Hong Cui (3 out of 3 patents)

7.  Xiujun Sun (3 out of 3 patents)

8.  Kenneth A Mendoza (2 out of 3 patents)

9.  David Garman (2 out of 3 patents)

10.  Frieder Hofmann (1 out of 1 patent)

11.  James Gurd (1 out of 1 patent)

12.  Crystal Dykstra (1 out of 1 patent)

13.  Rongwen Li (1 out of 1 patent)

14.  Andrew Tasker (1 out of 2 patents)

15.  Tracy Doucette (1 out of 4 patents)


Core Competencies:
Ischemia
Combination Therapy
Neurological Disease
TAT-NR2B9C
Lyophilized Formulation
Subarachnoid Hemorrhage
Pain Management
Small Molecule Inhibitors
Stroke Treatment
Internalization Peptide
Anxiety Treatment
Traumatic Injury

38 patents:

1. 11911438 - Chloride salt of TAT-NR2B9C (2024-02-27),
2. 11878044 - Combination therapy for ischemia (2024-01-23),
3. 11338015 - Therapy for subarachnoid hemorrhage and ischemia (2022-05-24),
4. 11266714 - Chloride salt of TAT-NR2B9C (2022-03-08),
5. 10967041 - Combination therapy for ischemia (2021-04-06),
6. 10912817 - Prelyophilized, lyophilized and reconstituted formulations comprising TAT-NR2B9C with d-amino acids, histidine and trehalose (2021-02-09),
7. 10758589 - Chloride salt of TAT-NR2B9c (2020-09-01),
8. 10300110 - Therapy for subarachnoid hemorrhage and ischemia (2019-05-28),
9. 10251935 - Lyophilized formulation comprising tat-NR2B9C, histidine and trehalose (2019-04-09),
10. 10206973 - Chloride salt of TAT-NR2B9c (2019-02-19),
11. 10206878 - Lyophilized formulation of TAT-NR2B9C with acetylation scavenger (2019-02-19),
12. 10064910 - Combination therapy for ischemia (2018-09-04),
13. 10046060 - Co-administration of an agent linked to an internalization peptide with an anti-inflammatory (2018-08-14),
14. 9629892 - Treatment of penetrative injury to the brain (2017-04-25),
15. 9610323 - Model systems and treatment regimes for treatment of neurological disease (2017-04-04),
Company Overview
Nono Inc. is a Toronto-based company specializing in advanced nanotechnology solutions. The organization focuses on the development and manufacturing of innovative materials and devices that leverage nanoscale properties to enhance performance across various applications. With a strong emphasis on research and development, Nono Inc. aims to push the boundaries of technology in sectors such as electronics, healthcare, and environmental sustainability, contributing to the advancement of next-generation products and solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Nono Inc. USPTO Patent Assignee Logo
38 Patents

#36 in Toronto

#357 in Canada

#17,860 in the World

Toronto, CA
Toronto, Canada

Nono Inc.

Forward Citations = 212

17 inventors:

goldMedal Michael Tymianski (30 out of 33 patents)

silverMedal Jonathan David Garman (24 out of 28 patents)

bronzeMedal Michael P Belmares (8 out of 19 patents)

4.  Peter S Lu (8 out of 25 patents)

5.  Michael W Salter (5 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nono Inc.. Retrieved from https://idiyas.com/company/nono

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…